Axovant fails while Pfizer leaves – the grim outlook of Alzheimer’s research
In yet another setback to the treatment of Alzheimer’s disease, Axovant Sciences...
Immunotherapy: the future of Alzheimer’s research?
Alzheimer’s research may see a well needed boost in the form of...
